Gene amplification, overexpression, and mutation of human epidermal growth factor receptor 2 (HER2), a transmembrane tyrosine kinase, are observed in approximately 20% of breast cancers and are associated with poor prognosis1,2. The gene discussed is ERBB2; the disease is breast cancer.